|
|
|
Volumn 62, Issue 3, 2016, Pages 262-272
|
|
Structure-guided, target-based drug discovery - exploiting genome information from HIV to mycobacterial infections
a a a a |
|
Author keywords
drug design discovery; fragment based; HIV protease; inhibitors; Mycobacterium abscessus; Mycobacterium tuberculosis; structure guided
|
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIINFECTIVE AGENT;
PROTEIN;
ANTAGONISTS AND INHIBITORS;
BINDING SITE;
CHEMISTRY;
CRYSTALLOGRAPHY;
DRUG DEVELOPMENT;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
METABOLISM;
MYCOBACTERIOSIS;
PROCEDURES;
PROTEIN CONFORMATION;
STRUCTURE ACTIVITY RELATION;
ANTI-BACTERIAL AGENTS;
ANTI-HIV AGENTS;
BINDING SITES;
CRYSTALLOGRAPHY;
DRUG DISCOVERY;
HIV INFECTIONS;
HUMANS;
MYCOBACTERIUM INFECTIONS;
PROTEIN CONFORMATION;
PROTEINS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
|
EID: 85026841115
PISSN: 00325422
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (0)
|